
Kidney cancer (also referred to as renal cell cancer) includes renal cell carcinoma and renal pelvis carcinoma. According to the American Cancer Society, the most common type of kidney cancer is renal cell cancer which accounts for 85 percent of all kidney tumors.
Kidney cancer is fairly resistant to radiation and chemotherapy. As a result, the gold standard treatment for localized kidney cancer is removal of the kidney or kidney tumors. Kidney surgery is traditionally performed using an open approach, meaning doctors must make a large incision in the abdomen.
Robotic surgery for kidney cancer incorporates the best techniques of open surgery and applies them to a robotic-assisted, minimally invasive approach. The precision and dexterity of advanced instrumentation facilitates a minimally invasive approach for treating kidney cancer.
Surgeons at the USC Institute of Urology have performed more than 1,000 minimally invasive partial nephrectomies for renal tumors, having by far the most experience in this type of surgery throughout the world. Our surgeons have well established experience in treating some of the most complex tumors such as:
• Hilar tumors
• Tumors in just one kidney
• Cystic lesions
• Multiple tumors